Skip to content

Short-term Outcomes of Full Bowel Preparation (MBP+OA) for Colon Cancer Resections Versus no Bowel Preparation

Short-term Outcomes of Full Bowel Preparation (MBP+OA) for Colon Resections for Cancer Versus no Bowel Preparation

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05546892
Acronym
COLRABI
Enrollment
586
Registered
2022-09-21
Start date
2023-02-10
Completion date
2025-09-30
Last updated
2023-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon Cancer

Keywords

colon cancer, MBP, bowel preparation, oral antibiotics

Brief summary

The purpose of the study is to determine if short-term outcomes of colon resections after full bowel preparation (mechanical bowel preparation plus oral antibiotics) are superior to colon resections with no bowel preparation.

Detailed description

The design involves random allocation of eligible patients to full bowel preparation or no bowel preparation in 1:1 ratio. After that colon resection is performed in both groups. Short-term outcomes are assessed in 30 day period after surgery. This is a superiority trial evaluating statistical superiority. Rate of anastomotic leak is anticipated to decrease from 8% (data from local registry) to 3%. For power of 80% enrolment of 586 patients is required. The intent-to-treat principle is used for the data analysis.

Interventions

PROCEDUREFull bowel preparation prior to colon resection for cancer

Mechanical bowel preparation and oral antibiotics

Omission of any bowel preparation

Sponsors

N.N. Petrov National Medical Research Center of Oncology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* histologically confirmed adenocarcinoma of the colon (caecum, ascending, transverse, descending, sigmoid) * clinical stage T1-4aN0-2M0-1 (distant metastases must be resectable) * indications for surgical colonic resection * ECOG status 0-2 * At least 18 years of age * Written informed consent

Exclusion criteria

* Medical or psychiatric conditions that compromise the patient's ability to give informed consent or comply with the study protocol * Pregnancy or breast feeding * Medical contraindications for surgical treatment * Any use of antibiotics 30 days prior to inclusion * Functioning stoma * Contraindications for use of MBP or OA drugs or their components * Indications for mandatory MBP (planned intraoperative colonoscopy etc) * Indications for obstructive resection * Acute bowel obstruction, bleeding or perforation * Other malignancies not in remission

Design outcomes

Primary

MeasureTime frameDescription
Anastomotic leak rate30 daysRate of anastomotic leak in patients after colon resections

Secondary

MeasureTime frameDescription
Intraabdominal and or pelvic abscess rate30 daysRate of intraabdominal and or pelvic abscess
Overall morbidity30 daysRate of patients with any complications after surgery
Rate of intraoperative complicationsDuration of surgical procedureRate of patients with intraoperative complications
Surgical site infection (SSI) rate30 daysRate of Surgical site infection
Quality of bowel preparation assessed by surgeonDay of surgical procedureAssessment of bowel preparation quality by surgeon (qualitative scale)
Bowel preparation complianceDay of surgical procedureRate of patients in experimental arm undergoing complete bowel preparation according to protocol
Surgery duration in minutesDuration of surgical procedureTime of surgical procedure

Countries

Russia

Contacts

Primary ContactAleksei Karachun
dr.a.karachun@gmail.com+79219462123
Backup ContactAleksei Petrov
alexpetrov@doctor.com+79214117866

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026